Skip to main content

Table 2 Percentages of respondents with correct answers to questions on various sickle cell disease topics

From: Assessment of healthcare workers’ knowledge and availability of resources for sickle cell disease management in Bukavu, Democratic Republic of the Congo

Topics of questions asked

Doctor

(n=165), n(%)

Nurse

(n= 336), n(%)

Total

N=501, n(%)

p-value

Neonatal Screening Program

114 (69.1)

210 (62.5)

324 (64.7)

0.1469

Sickle Cell Condition

124 (75.2)

179 (53.3)

303 (60.5)

<0.0001

Sickle Cell Anemia Genotype

140 (84.9)

272 (80.9)

412 (82.2)

0.2836

Sickle Cell Trait

14 (8.5)

22 (6.6)

36 (7.2)

0.4301

Sickle cell disease manifestations

56 (33.9)

57 (17.0)

113 (22.6)

<0.0001

Vaso-occlusion

114 (69.1)

145 (43.2)

259 (51.7)

<0.0001

Factors that favor red blood cells sickling

93 (56.4)

66 (19.6)

159 (31.7)

<0.0001

Warning Signs

13 (7.9)

13 (3.9)

26 (5.2)

0.0572

Medications used in prevention and/or treatment of sickle cell disease

67 (40.6)

46 (13.7)

113 (22.6)

<0.0001

Use of antibiotics

51 (30.9)

84 (25.0)

135 (27.0)

0.1612

Adolescent Health

61 (37.0)

56 (16.7)

117 (23.4)

<0.0001

Pregnancy and contraception

30 (18.2)

57 (17.0)

87 (17.4)

0.7353

Care for prevention of leg ulcers

95 (57.6)

140 (41.7)

235 (46.9)

0.0011